Loading...
XSHE
000813
Market cap1.19bUSD
Dec 05, Last price  
4.01CNY
1D
0.75%
1Q
-5.87%
Jan 2017
-58.32%
Name

Dezhan Healthcare Co Ltd

Chart & Performance

D1W1MN
XSHE:000813 chart
P/E
P/S
18.03
EPS
Div Yield, %
Shrs. gr., 5y
-0.63%
Rev. gr., 5y
-23.45%
Revenues
466m
-6.34%
358,075,854310,956,678338,080,796381,218,752248,879,079296,633,730300,757,145257,304,950569,175,768559,371,797510,772,7491,442,998,6252,220,294,8183,290,827,5921,774,968,109962,867,939734,479,885570,855,435498,088,171466,485,016
Net income
-20m
L
9,895,75712,665,54115,546,8512,198,75106,322,7833,471,827026,256,52321,503,6366,159,630661,671,880797,177,693930,525,670336,921,030284,544,4080083,314,246-20,413,065
CFO
-15m
L
134,831,22922,624,834056,526,56236,027,0870016,510,559170,585,210136,465,461124,913,816262,356,181384,636,714379,780,8701,558,808,735827,536,28842,409,946161,719,681127,872,780-14,589,208
Dividend
Jun 01, 20210.21 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dezhan Healthcare Company Limited researches and develops, manufactures, and sells cardiovascular and cerebrovascular drugs in China. It also offers anti-cancer drugs, health care products, functional beverages, and ecological water. The company was founded in 1998 and is based in Urumqi, China.
IPO date
May 19, 1998
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT